Methods for expressing and targeting mitochondrial-DNA-encoded peptides and uses thereof
OwnerGiovanni Manfredi, Eric A. Schoninventors
Life of this patent
Estimating the term…
Loading patent…
OwnerGiovanni Manfredi, Eric A. Schoninventors
Estimating the term…
The present invention provides methods for introducing functional peptides into organelles. Additionally, the present invention provides a method for correcting a phenotypic deficiency in a mammal that results from a mutation in the mammal's mitochondrial DNA (mtDNA). The present invention further provides a method for treating a mitochondrial disorder in a subject in need of treatment therefor. Also provided is an expression vector that is useful for introducing a functional peptide encoded by an mtDNA sequence into a mitochondrion. The present invention also provides eukaryotic cells transformed by expression vectors that are useful for introducing functional peptides into organelles. Finally, the present invention provides a pharmaceutical composition comprising a non-nuclear nucleic acid sequence encoding a peptide for introduction into an organelle, a nucleic acid sequence encoding an organelle-targeting signal, and a pharmaceutically-acceptable carrier.
A method for introducing a functional peptide encoded by a non-nuclear nucleic acid sequence into an organelle, comprising the steps of:
A method for introducing a functional peptide encoded by a mitochondrial DNA (mtDNA) sequence into an organelle, comprising the steps of:
A method for correcting a phenotypic deficiency in a mammal that results from a mutation in a peptide-encoding sequence of the mammal's mitochondrial DNA (mtDNA), comprising the steps of:
A method for treating a mitochondrial disorder in a subject in need of treatment therefor, comprising administering to the subject a mitochondrial-DNA-encoded (mtDNA-encoded) peptide in an amount effective to treat the mitochondrial disorder.
An expression vector that is useful for introducing a functional peptide encoded by a mitochondrial DNA (mtDNA) sequence into a mitochondrion, comprising:
A eukaryotic cell transformed by an expression vector that is useful for introducing a functional peptide encoded by a non-nuclear nucleic acid sequence into an organelle, wherein the eukaryotic cell is derived from algae, an animal, a multicellular or other non-yeast fungus, or protozoa, and the expression vector comprises:
A eukaryotic cell transformed by an expression vector that is useful for introducing a functional peptide encoded by a mitochondrial DNA (mtDNA) sequence into an organelle, wherein the eukaryotic cell is derived from algae, an animal, a multicellular or other non-yeast fungus, a plant, or protozoa, and the expression vector comprises:
A pharmaceutical composition, comprising:
Dependencies are inferred from the claim text.